Mount Yale Investment Advisors’s Neuraxis NRXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Buy
14,300
+3,300
+30% +$24.4K ﹤0.01% 1172
2026
Q1
$81.4K Buy
+11,000
New +$60.2K ﹤0.01% 1082

Other funds holding NRXS

Mount Yale Investment Advisors's NRXS Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its Neuraxis (NRXS) stake by 30% in Q2 2026, buying an estimated $24.4K and bringing the position to 14,300 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Mount Yale Investment Advisors first reported a position in NRXS in Q1 2026 and has held it in 2 quarters since. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Mount Yale Investment Advisors held 14,300 shares of Neuraxis worth $105K as of Q2 2026.
  • Mount Yale Investment Advisors bought 3,300 Neuraxis shares in Q2 2026, an estimated $24.4K.
  • Neuraxis made up ﹤0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #1172 holding.
  • Mount Yale Investment Advisors first reported a position in Neuraxis in Q1 2026 and has held it in 2 quarters since.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.